Claravis 30 MG capsule 10S
Ended Awarded
- Contract number
- SPE2DB25FFCJ1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $84,809
Award facts
- Contract value 100% obligated
- $84,809.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $84,809.32 to AmerisourceBergen Drug Corp for the supply of Claravis 30 mg capsules (10-count packages). This competitively awarded, firm fixed-price delivery order was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. The contract represents a non-set-aside procurement, and fulfillment will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Claravis is an isotretinoin-based pharmaceutical product used primarily for severe acne treatment, reflecting the company's role as a critical pharmaceutical distributor supporting federal medical supply chains.
This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a major pharmaceutical distributor and established federal contractor, AmerisourceBergen demonstrates the capability to meet competitive federal procurement requirements across diverse therapeutic domains and supply scales.
Quick answers
Who was awarded contract SPE2DB25FFCJ1?
SPE2DB25FFCJ1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FFCJ1 worth?
The government has obligated $84,809 on SPE2DB25FFCJ1.
Is contract SPE2DB25FFCJ1 an order under another contract?
Yes. SPE2DB25FFCJ1 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FFCJ1 competed?
The extent of competition for SPE2DB25FFCJ1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award